免疫腫瘍学治療の世界市場 2020年

• 英文タイトル：Global Immuno-Oncology Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115644 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、免疫腫瘍学治療の世界市場を調査対象にし、免疫腫瘍学治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（免疫チェックポイント阻害剤、モノクローナル抗体、サイトカインベース免疫療法、癌ワクチン、CAR-T細胞療法）、用途別分析（病院、外来外科センター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Amgen、Merck、Eli-Lilly、AstraZeneca、Janssen Biotech、Bristol-Myers Squibb、Pfizer、GlaxoSmithKline、Roche、Novartis、Sanofi、Spectrum Pharmaceuticals、Takeda ・企業別売上、市場シェア ・免疫腫瘍学治療の地域別市場分析 ・免疫腫瘍学治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・免疫腫瘍学治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・免疫腫瘍学治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・免疫腫瘍学治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・免疫腫瘍学治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・免疫腫瘍学治療の種類別市場規模2015-2020：免疫チェックポイント阻害剤、モノクローナル抗体、サイトカインベース免疫療法、癌ワクチン、CAR-T細胞療法 ・免疫腫瘍学治療の用途別市場規模2015-2020：病院、外来外科センター、その他 ・免疫腫瘍学治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Immuno-Oncology Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Immuno-Oncology Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Immuno-Oncology Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Immuno-Oncology Treatment market has been segmented into:
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy

By Application, Immuno-Oncology Treatment has been segmented into:
Hospitals
Ambulatory Surgical Center
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Immuno-Oncology Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Immuno-Oncology Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Immuno-Oncology Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Immuno-Oncology Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Immuno-Oncology Treatment Market Share Analysis
Immuno-Oncology Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Immuno-Oncology Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Immuno-Oncology Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Immuno-Oncology Treatment are:
Amgen
Merck
Eli-Lilly
AstraZeneca
Janssen Biotech
Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Roche
Novartis
Sanofi
Spectrum Pharmaceuticals
Takeda

レポート目次

---

Table of Contents

1 Immuno-Oncology Treatment Market Overview
1.1 Product Overview and Scope of Immuno-Oncology Treatment
1.2 Classification of Immuno-Oncology Treatment by Type
1.2.1 Global Immuno-Oncology Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Immuno-Oncology Treatment Revenue Market Share by Type in 2019
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Monoclonal Antibodies
1.2.5 Cytokine-Based Immunotherapy
1.2.6 Cancer Vaccines
1.2.7 CAR-T Cell Therapy
1.3 Global Immuno-Oncology Treatment Market by Application
1.3.1 Overview: Global Immuno-Oncology Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Global Immuno-Oncology Treatment Market by Regions
1.4.1 Global Immuno-Oncology Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Immuno-Oncology Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Immuno-Oncology Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Immuno-Oncology Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immuno-Oncology Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Immuno-Oncology Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immuno-Oncology Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli-Lilly
2.3.1 Eli-Lilly Details
2.3.2 Eli-Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli-Lilly SWOT Analysis
2.3.4 Eli-Lilly Product and Services
2.3.5 Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Janssen Biotech
2.5.1 Janssen Biotech Details
2.5.2 Janssen Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Janssen Biotech SWOT Analysis
2.5.4 Janssen Biotech Product and Services
2.5.5 Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bristol-Myers Squibb SWOT Analysis
2.6.4 Bristol-Myers Squibb Product and Services
2.6.5 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline SWOT Analysis
2.8.4 GlaxoSmithKline Product and Services
2.8.5 GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis SWOT Analysis
2.10.4 Novartis Product and Services
2.10.5 Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sanofi SWOT Analysis
2.11.4 Sanofi Product and Services
2.11.5 Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Spectrum Pharmaceuticals
2.12.1 Spectrum Pharmaceuticals Details
2.12.2 Spectrum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Spectrum Pharmaceuticals SWOT Analysis
2.12.4 Spectrum Pharmaceuticals Product and Services
2.12.5 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Takeda SWOT Analysis
2.13.4 Takeda Product and Services
2.13.5 Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Immuno-Oncology Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Immuno-Oncology Treatment Players Market Share
3.2.2 Top 10 Immuno-Oncology Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Immuno-Oncology Treatment Revenue and Market Share by Regions
4.2 North America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5 North America Immuno-Oncology Treatment Revenue by Countries
5.1 North America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
5.2 USA Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6 Europe Immuno-Oncology Treatment Revenue by Countries
6.1 Europe Immuno-Oncology Treatment Revenue by Countries (2015-2020)
6.2 Germany Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.4 France Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Immuno-Oncology Treatment Revenue by Countries
7.1 Asia-Pacific Immuno-Oncology Treatment Revenue by Countries (2015-2020)
7.2 China Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.5 India Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
8 South America Immuno-Oncology Treatment Revenue by Countries
8.1 South America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
8.2 Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Immuno-Oncology Treatment by Countries
9.1 Middle East & Africa Immuno-Oncology Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Immuno-Oncology Treatment Market Forecast by Type (2019-2024)
10.3 Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2025)
10.4 Monoclonal Antibodies Revenue Growth Rate (2015-2025)
10.5 Cytokine-Based Immunotherapy Revenue Growth Rate (2015-2025)
10.6 Cancer Vaccines Revenue Growth Rate (2015-2025)
10.7 CAR-T Cell Therapy Revenue Growth Rate (2015-2025)
11 Global Immuno-Oncology Treatment Market Segment by Application
11.1 Global Immuno-Oncology Treatment Revenue Market Share by Application (2015-2020)
11.2 Immuno-Oncology Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Center Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Immuno-Oncology Treatment Market Size Forecast (2021-2025)
12.1 Global Immuno-Oncology Treatment Market Size Forecast (2021-2025)
12.2 Global Immuno-Oncology Treatment Market Forecast by Regions (2021-2025)
12.3 North America Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
12.6 South America Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Immuno-Oncology Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Immuno-Oncology Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Immuno-Oncology Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Immuno-Oncology Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Amgen Corporate Information, Location and Competitors
Table 6. Amgen Immuno-Oncology Treatment Major Business
Table 7. Amgen Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Amgen SWOT Analysis
Table 9. Amgen Immuno-Oncology Treatment Product and Solutions
Table 10. Amgen Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Merck Corporate Information, Location and Competitors
Table 12. Merck Immuno-Oncology Treatment Major Business
Table 13. Merck Immuno-Oncology Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Merck SWOT Analysis
Table 15. Merck Immuno-Oncology Treatment Product and Solutions
Table 16. Merck Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eli-Lilly Corporate Information, Location and Competitors
Table 18. Eli-Lilly Immuno-Oncology Treatment Major Business
Table 19. Eli-Lilly Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Eli-Lilly SWOT Analysis
Table 21. Eli-Lilly Immuno-Oncology Treatment Product and Solutions
Table 22. Eli-Lilly Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AstraZeneca Corporate Information, Location and Competitors
Table 24. AstraZeneca Immuno-Oncology Treatment Major Business
Table 25. AstraZeneca Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 26. AstraZeneca SWOT Analysis
Table 27. AstraZeneca Immuno-Oncology Treatment Product and Solutions
Table 28. AstraZeneca Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Janssen Biotech Corporate Information, Location and Competitors
Table 30. Janssen Biotech Immuno-Oncology Treatment Major Business
Table 31. Janssen Biotech Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Janssen Biotech SWOT Analysis
Table 33. Janssen Biotech Immuno-Oncology Treatment Product and Solutions
Table 34. Janssen Biotech Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 36. Bristol-Myers Squibb Immuno-Oncology Treatment Major Business
Table 37. Bristol-Myers Squibb Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Bristol-Myers Squibb SWOT Analysis
Table 39. Bristol-Myers Squibb Immuno-Oncology Treatment Product and Solutions
Table 40. Bristol-Myers Squibb Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pfizer Corporate Information, Location and Competitors
Table 42. Pfizer Immuno-Oncology Treatment Major Business
Table 43. Pfizer Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Pfizer SWOT Analysis
Table 45. Pfizer Immuno-Oncology Treatment Product and Solutions
Table 46. Pfizer Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GlaxoSmithKline Corporate Information, Location and Competitors
Table 48. GlaxoSmithKline Immuno-Oncology Treatment Major Business
Table 49. GlaxoSmithKline Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 50. GlaxoSmithKline SWOT Analysis
Table 51. GlaxoSmithKline Immuno-Oncology Treatment Product and Solutions
Table 52. GlaxoSmithKline Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Immuno-Oncology Treatment Major Business
Table 55. Roche Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Immuno-Oncology Treatment Product and Solutions
Table 58. Roche Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Novartis Corporate Information, Location and Competitors
Table 60. Novartis Immuno-Oncology Treatment Major Business
Table 61. Novartis Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Novartis SWOT Analysis
Table 63. Novartis Immuno-Oncology Treatment Product and Solutions
Table 64. Novartis Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Sanofi Corporate Information, Location and Competitors
Table 66. Sanofi Immuno-Oncology Treatment Major Business
Table 67. Sanofi Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Sanofi SWOT Analysis
Table 69. Sanofi Immuno-Oncology Treatment Product and Solutions
Table 70. Sanofi Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Spectrum Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Spectrum Pharmaceuticals Immuno-Oncology Treatment Major Business
Table 73. Spectrum Pharmaceuticals Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Spectrum Pharmaceuticals SWOT Analysis
Table 75. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Solutions
Table 76. Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Takeda Corporate Information, Location and Competitors
Table 78. Takeda Immuno-Oncology Treatment Major Business
Table 79. Takeda Immuno-Oncology Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Takeda SWOT Analysis
Table 81. Takeda Immuno-Oncology Treatment Product and Solutions
Table 82. Takeda Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Immuno-Oncology Treatment Revenue (Million USD) by Players (2015-2020)
Table 84. Global Immuno-Oncology Treatment Revenue Share by Players (2015-2020)
Table 85. Global Immuno-Oncology Treatment Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Immuno-Oncology Treatment Revenue Market Share by Regions (2015-2020)
Table 87. North America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table 88. North America Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Table 89. Europe Immuno-Oncology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Immuno-Oncology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table 92. South America Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Immuno-Oncology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Table 95. Global Immuno-Oncology Treatment Revenue (Million USD) by Type (2015-2020)
Table 96. Global Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table 97. Global Immuno-Oncology Treatment Revenue Forecast by Type (2021-2025)
Table 98. Global Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table 99. Global Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Table 100. Global Immuno-Oncology Treatment Revenue Forecast by Application (2021-2025)
Table 101. Global Immuno-Oncology Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Immuno-Oncology Treatment Picture
Figure 2. Global Immuno-Oncology Treatment Revenue Market Share by Type in 2019
Figure 3. Immune Checkpoint Inhibitors Picture
Figure 4. Monoclonal Antibodies Picture
Figure 5. Cytokine-Based Immunotherapy Picture
Figure 6. Cancer Vaccines Picture
Figure 7. CAR-T Cell Therapy Picture
Figure 8. Immuno-Oncology Treatment Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Ambulatory Surgical Center Picture
Figure 11. Others Picture
Figure 12. Global Immuno-Oncology Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Immuno-Oncology Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Immuno-Oncology Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Immuno-Oncology Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Immuno-Oncology Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Immuno-Oncology Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure 45. China Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Immuno-Oncology Treatment Revenue Share by Type in 2019
Figure 62. Global Immuno-Oncology Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020)
Figure 64. Global Monoclonal Antibodies Revenue Growth Rate (2015-2020)
Figure 65. Global Cytokine-Based Immunotherapy Revenue Growth Rate (2015-2020)
Figure 66. Global Cancer Vaccines Revenue Growth Rate (2015-2020)
Figure 67. Global CAR-T Cell Therapy Revenue Growth Rate (2015-2020)
Figure 68. Global Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure 69. Global Immuno-Oncology Treatment Revenue Share by Application in 2019
Figure 70. Global Immuno-Oncology Treatment Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Ambulatory Surgical Center Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Immuno-Oncology Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Immuno-Oncology Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Immuno-Oncology Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---